SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-23-011647
Filing Date
2023-04-28
Accepted
2023-04-28 16:45:25
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A nby20230422_10ka.htm   iXBRL 10-K/A 377842
2 EXHIBIT 31.1 ex_507665.htm EX-31.1 3701
3 EXHIBIT 31.2 ex_507666.htm EX-31.2 3539
  Complete submission text file 0001437749-23-011647.txt   627593

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nby-20221231.xsd EX-101.SCH 3593
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20221231_def.xml EX-101.DEF 17160
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20221231_lab.xml EX-101.LAB 23278
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20221231_pre.xml EX-101.PRE 18141
9 EXTRACTED XBRL INSTANCE DOCUMENT nby20230422_10ka_htm.xml XML 5931
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33678 | Film No.: 23867495
SIC: 2834 Pharmaceutical Preparations